Embolic protection during saphenous vein graft interventions

Subhash Banerjee, Emmanouil S. Brilakis

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.

Original languageEnglish (US)
Pages (from-to)415-417
Number of pages3
JournalJournal of Invasive Cardiology
Issue number8
StatePublished - Aug 1 2009

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Embolic protection during saphenous vein graft interventions'. Together they form a unique fingerprint.

Cite this